Point72 Middle East FZE’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Point72 Middle East FZE’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-94	Closed	-$2.27K	–	2186
2023 Q1	$2.27K	Buy	+94	New	+$1.18K	﹤0.01%	1539

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Point72 Middle East FZE's PRVB Position: Q2 2023 in Review

Point72 Middle East FZE sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 94 shares — an estimated $2.27K sold.

Point72 Middle East FZE first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $2.27K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Point72 Middle East FZE reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Point72 Middle East FZE sold 94 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $2.27K.
Point72 Middle East FZE first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Point72 Middle East FZE's Provention Bio, Inc. Common Stock position peaked at $2.27K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Point72 Middle East FZE's 13F filing for Q2 2023, filed 14 Aug 2023.